Outset Medical (OM) saw its shares surge by a remarkable 25.44% during Wednesday’s after-hours session, traded around $16.52. The trigger for this impressive upward trajectory was the company’s recently released Q2 2025 financial results.
Outset Medical reported a revenue of $31.4 million, a 7.18% improvement on the estimated $29.3 million and a significant 14.68% increase compared to Q2 2024. The company also posted an adjusted loss per share of $0.84, considerably better than both the predicted loss of $0.98 and the loss of $7.05 per share reported in the same period last year.
